Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Recurrence 1Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Laryngeal Diseases 1Hypoxia 1Head and Neck Neoplasms 1

Interventions

Cisplatin 41Radiotherapy 28Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 11Paclitaxel 10Cetuximab 10Carboplatin 8Immunohistochemistry 6Platinum 5Radiotherapy, Conformal 4Gene Expression Profiling 4Drug Therapy 4Chemotherapy, Adjuvant 4durvalumab 3Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Afatinib 31,2-diaminocyclohexaneplatinum II citrate 3vandetanib 2Taxes 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiation 2Panitumumab 2Nimorazole 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2In Situ Hybridization 2Fluorodeoxyglucose F18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Squamous Cell Carcinoma of Head and Neck × Nimorazole × Clear all
NCT02661152 2021-04-13

DAHANCA30

Danish Head and Neck Cancer Group

Phase 3 Unknown
1,252 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT01733823 2017-07-28

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

Danish Head and Neck Cancer Group

Phase 1/2 Completed
31 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡